Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy

JH Doring; A Saffari; T Bast; K Brockmann; L Ehrhardt; W Fazeli; WG Janzarik; A Klabunde-Cherwon; Gerhard Kluger; H Muhle; M Pendziwiat; RS Moller; K Platzer; JL Santos; J Schroter; GF Hoffmann; S Kolker; S Syrbe

doi:10.1212/NXG.0000000000200020

Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy

JH Doring, A Saffari, T Bast, K Brockmann, L Ehrhardt, W Fazeli, WG Janzarik, A Klabunde-Cherwon, Gerhard Kluger (Co-author), H Muhle, M Pendziwiat, RS Moller, K Platzer, JL Santos, J Schroter, GF Hoffmann, S Kolker, S Syrbe

Research output: Contribution to journal › Original Article › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	e200020
Journal	NEUROLOGY-GENETICS
Volume	8
Issue number	5
DOIs	https://doi.org/10.1212/NXG.0000000000200020
Publication status	Published - 2022

Keywords

PAROXYSMAL KINESIGENIC DYSKINESIA
PRRT2
MUTATIONS
LEVETIRACETAM
GUIDELINES
PHENOTYPE
VARIANTS

Access to Document

10.1212/NXG.0000000000200020

Cite this

Doring, JH., Saffari, A., Bast, T., Brockmann, K., Ehrhardt, L., Fazeli, W., Janzarik, WG., Klabunde-Cherwon, A., Kluger, G., Muhle, H., Pendziwiat, M., Moller, RS., Platzer, K., Santos, JL., Schroter, J., Hoffmann, GF., Kolker, S., & Syrbe, S. (2022). Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy. NEUROLOGY-GENETICS, 8(5), e200020. https://doi.org/10.1212/NXG.0000000000200020

@article{a87ce24d65a24f58be93c4acae8e1581,

title = "Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy",

keywords = "PAROXYSMAL KINESIGENIC DYSKINESIA, PRRT2, MUTATIONS, LEVETIRACETAM, GUIDELINES, PHENOTYPE, VARIANTS",

author = "JH Doring and A Saffari and T Bast and K Brockmann and L Ehrhardt and W Fazeli and WG Janzarik and A Klabunde-Cherwon and Gerhard Kluger and H Muhle and M Pendziwiat and RS Moller and K Platzer and JL Santos and J Schroter and GF Hoffmann and S Kolker and S Syrbe",

note = "Kluger, G: Research Institute for Rehabilitation (G.K.), Transition and Palliation, PMU Salzburg, Austria",

year = "2022",

doi = "10.1212/NXG.0000000000200020",

language = "English",

volume = "8",

pages = "e200020",

journal = "NEUROLOGY-GENETICS",

issn = "2376-7839",

publisher = "Lippincott Williams & Wilkins ",

number = "5",

}

Doring, JH, Saffari, A, Bast, T, Brockmann, K, Ehrhardt, L, Fazeli, W, Janzarik, WG, Klabunde-Cherwon, A, Kluger, G, Muhle, H, Pendziwiat, M, Moller, RS, Platzer, K, Santos, JL, Schroter, J, Hoffmann, GF, Kolker, S & Syrbe, S 2022, 'Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy', NEUROLOGY-GENETICS, vol. 8, no. 5, pp. e200020. https://doi.org/10.1212/NXG.0000000000200020

TY - JOUR

T1 - Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy

AU - Doring, JH

AU - Saffari, A

AU - Bast, T

AU - Brockmann, K

AU - Ehrhardt, L

AU - Fazeli, W

AU - Janzarik, WG

AU - Klabunde-Cherwon, A

AU - Kluger, Gerhard

AU - Muhle, H

AU - Pendziwiat, M

AU - Moller, RS

AU - Platzer, K

AU - Santos, JL

AU - Schroter, J

AU - Hoffmann, GF

AU - Kolker, S

AU - Syrbe, S

N1 - Kluger, G: Research Institute for Rehabilitation (G.K.), Transition and Palliation, PMU Salzburg, Austria

PY - 2022

Y1 - 2022

KW - PAROXYSMAL KINESIGENIC DYSKINESIA

KW - PRRT2

KW - MUTATIONS

KW - LEVETIRACETAM

KW - GUIDELINES

KW - PHENOTYPE

KW - VARIANTS

U2 - 10.1212/NXG.0000000000200020

DO - 10.1212/NXG.0000000000200020

M3 - Original Article

C2 - 36187725

SN - 2376-7839

VL - 8

SP - e200020

JO - NEUROLOGY-GENETICS

JF - NEUROLOGY-GENETICS

IS - 5

ER -